首页> 美国卫生研究院文献>other >Quantification of Regulatory T Cells in Septic Patients by Real-Time PCR–Based Methylation Assay and Flow Cytometry
【2h】

Quantification of Regulatory T Cells in Septic Patients by Real-Time PCR–Based Methylation Assay and Flow Cytometry

机译:败血症患者的调节性T细胞的实时pCR为基础的甲基化分析和流式细胞仪的量化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

During sepsis, a relative increase of regulatory T (Treg) cells has been reported. Its persistence is associated with lymphocyte anergy, immunoparalysis and a poor prognosis. Currently, an exact quantification of human Treg cells based on protein expression of marker molecules is ambiguous, as these molecules are expressed also by activated non-regulatory T cells. Furthermore, no firm criteria for flow cytometer gate settings exist so far. Recently, a specific DNA methylation pattern within FOXP3-TSDR has been reported that allows distinguishing Treg and non-regulatory T cells, independent of their activation status. Using this epigenetic marker, we established a single-tube real-time PCR based methylation assay (QAMA) for relative quantification of Treg cells. Validation was performed on defined ratios of methylated and unmethylated target sequence and on mixtures of Treg and non-regulatory T cells. DNA-methylation was measured in CD4+ T cells isolated from blood samples of 30 septic patients and 30 healthy subjects and compared with results of Treg cell quantification by flow cytometry based on CD4+ CD25hiCD127low measurement. In septic patients both methods showed an increased ratio of Treg cells to all CD4+ T cells. In healthy individuals, the results obtained by both methods were clearly positively correlated. However, the correlation between both methods in septic patients was only weak. We showed that quantification of Treg cells by QAMA detects CD4+ T cells with unmethylated FOXP3-TSDR, hidden in the CD25med/low fraction of flow cytometry. Given that unmethylated FOXP3-TSDR is the most specific feature of Treg cells to date, our assay precisely quantifies Treg cells, as it additionally detects those committed Treg cells, hidden in the CD25med/low fraction of CD4+ cells. Furthermore, QAMA is a reliable method, which is easier to standardize among laboratories and can thus improve reproducibility of Treg cell quantification.
机译:在脓毒症期间,据报道调节性T(Treg)细胞相对增加。其持续存在与淋巴细胞无反应,免疫麻痹和不良预后有关。当前,基于标记分子的蛋白质表达对人Treg细胞的精确定量是模棱两可的,因为这些分子也由活化的非调节性T细胞表达。此外,到目前为止,还没有针对流式细胞仪门设置的严格标准。最近,已经报道了FOXP3-TSDR内的一种特定的DNA甲基化模式,可以区分Treg和非调节性T细胞,而与它们的活化状态无关。使用这种表观遗传标记,我们建立了基于单管实时PCR的甲基化测定(QAMA),用于Treg细胞的相对定量。对甲基化和非甲基化靶序列的确定比例以及Treg和非调节性T细胞的混合物进行验证。从30名败血症患者和30名健康受试者的血液样本中分离的CD4 + T细胞中检测DNA甲基化,并与基于CD4 + CD25 hi CD127 low 测量。在败血病患者中,两种方法均显示Treg细胞与所有CD4 + T细胞的比率增加。在健康个体中,通过两种方法获得的结果显然呈正相关。然而,在败血病患者中这两种方法之间的相关性很弱。我们发现,通过QAMA对Treg细胞进行定量检测,可以检测到未甲基化的FOXP3-TSDR的CD4 + T细胞,该细胞隐藏在流式细胞仪CD25 med / low 部分。鉴于迄今为止未甲基化的FOXP3-TSDR是Treg细胞最具体的特征,我们的测定法可以精确定量Treg细胞,因为它还可以检测隐藏在CD4 CD25 med / low 部分中的那些定型Treg细胞。 + 单元格。此外,QAMA是一种可靠的方法,在实验室之间更易于标准化,因此可以提高Treg细胞定量的可重复性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号